Bristol-Myers Squibb Company (BMY) vs Johnson & Johnson (JNJ)
A side-by-side comparison of Bristol-Myers Squibb Company and Johnson & Johnson across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
BMY
Bristol-Myers Squibb Company
$63.60HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
JNJ
Johnson & Johnson
$266.73HealthcareAt close: Jul 28, 2026, 4:00 PM ET
Total return — BMY vs JNJ
growth of $100 · dividends reinvested · last 30yBMY +790.3%JNJ +2233.1%JNJ compounded faster
BMY JNJ
BMY vs JNJ: by the numbers
- •JNJ is the larger company ($642.79B vs $129.88B market cap).
- •BMY trades at the lower trailing earnings multiple (17.57 vs 30.91 P/E), one valuation lens rather than an overall verdict.
- •JNJ converts more revenue to profit (21.48% vs 15.01% net margin).
- •JNJ grew revenue faster over the past five years (2.93% vs 2.52% CAGR).
- •BMY pays the higher dividend yield (4.00% vs 1.96%).
Metrics side by side
Valuation
| Metric | BMY | JNJ |
|---|---|---|
| P/E ratio | 17.57 | 30.91 |
| Forward P/E | 9.86 | 22.83 |
| P/S ratio | 2.64 | 6.65 |
| P/B ratio | 6.37 | 7.66 |
| PEG ratio | 1.87 | 0.21 |
| EV / EBITDA | 10.34 | 20.04 |
| FCF yield | 9.31% | 3.47% |
Profitability
| Metric | BMY | JNJ |
|---|---|---|
| Gross margin | 68.75% | 70.45% |
| Operating margin | 25.67% | 26.81% |
| Net margin | 15.01% | 21.48% |
| ROE | 36.25% | 24.76% |
| ROIC | 13.90% | 13.71% |
Dividends
| Metric | BMY | JNJ |
|---|---|---|
| Dividend yield | 4.00% | 1.96% |
| Payout ratio | 72.25% | 47.51% |
Growth (annualized)
| Metric | BMY | JNJ |
|---|---|---|
| Revenue CAGR (5Y) | 2.52% | 2.93% |
| EPS CAGR (5Y) | 9.38% | 11.51% |
| FCF CAGR (5Y) | -2.50% | -0.49% |
| Total return CAGR (5Y) | 2.73% | 12.26% |
Frequently asked
- Which has the lower trailing P/E, BMY or JNJ?
- BMY has the lower trailing P/E: BMY trades at 17.57 and JNJ at 30.91. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BMY or JNJ?
- Over the past five years, JNJ grew revenue faster — BMY at a 2.52% CAGR versus JNJ at 2.93%.
- Does BMY or JNJ pay a bigger dividend?
- BMY yields 4.00% and JNJ yields 1.96% based on trailing dividends and the latest price.
- Is BMY or JNJ more profitable?
- JNJ runs the higher net margin — BMY at 15.01% versus JNJ at 21.48%.
- How have BMY and JNJ total returns compared?
- Over the past 10 years, BMY delivered 2.02% and JNJ delivered 10.91% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bristol-Myers Squibb P/E ratioJohnson & Johnson P/E ratioBristol-Myers Squibb dividend yieldJohnson & Johnson dividend yieldBristol-Myers Squibb ROEJohnson & Johnson ROEBristol-Myers Squibb operating marginJohnson & Johnson operating marginBristol-Myers Squibb revenue growthJohnson & Johnson revenue growthBristol-Myers Squibb free cash flowJohnson & Johnson free cash flow
Bristol-Myers Squibb & Johnson & Johnson appear in these rankings
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.